APA (7th ed.) Citation

Nakano, E., Ogata, D., Namikawa, K., & Yamazaki, N. (2025). Real‐World Efficacy and Safety of Anti‐PD‐1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single‐Center Retrospective Study in Japan. The Journal of dermatology, 52(7), 1219. https://doi.org/10.1111/1346-8138.17799

Chicago Style (17th ed.) Citation

Nakano, Eiji, Dai Ogata, Kenjiro Namikawa, and Naoya Yamazaki. "Real‐World Efficacy and Safety of Anti‐PD‐1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single‐Center Retrospective Study in Japan." The Journal of Dermatology 52, no. 7 (2025): 1219. https://doi.org/10.1111/1346-8138.17799.

MLA (9th ed.) Citation

Nakano, Eiji, et al. "Real‐World Efficacy and Safety of Anti‐PD‐1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single‐Center Retrospective Study in Japan." The Journal of Dermatology, vol. 52, no. 7, 2025, p. 1219, https://doi.org/10.1111/1346-8138.17799.